Type | Public | |
Founded | 1997 | |
HQ | Pencoed, GB | Map |
Website | reneuron.com |
GBP | |
---|---|
Revenue (FY, 2019) | 49.0k |
Net income (FY, 2019) | (14.3m) |
EBITDA (FY, 2019) | (18.0m) |
EBIT (FY, 2019) | (18.3m) |
Market capitalization (20-Jan-2021) | 70.8m |
Closing stock price (20-Jan-2021) | 1.2 |
Cash (31-Mar-2019) | 20.4m |
GBP | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 3.0k | 9.0k | 49.0k | 27.0k | 93.0k | 31.0k | 29.0k | 40.0k | 17.0k | 22.0 | 30.0k | 29.0k | 46.0k | 43.0k | 49.0k |
Revenue growth, % | 36% | (3%) | |||||||||||||
Operating expense total | 3.4m | (5.9m) | 6.0m | 6.9m | 4.8m | 6.2m | 6.9m | 7.1m | 8.0k | 10.4m | 13.8m | 19.9m | 20.4m | 18.3m | |
EBITDA | (5.8m) | (6.7m) | (4.5m) | (3.9m) | (6.7m) | (7.0m) | (7.9k) | (10.3m) | (13.7m) | (18.2m) | (20.1m) | (18.0m) |
GBP | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 70.0k | 5.1m | 7.7m | 2.8m | 943.0k | 5.5m | 9.7m | 4.0m | 3.5m | 14.9k | 12.4m | 17.4m | 53.1m | 27.9m | 20.4m |
Accounts Receivable | 386.0 | ||||||||||||||
Current Assets | 1.1m | 6.2m | 8.7m | 3.2m | 2.0m | 6.2m | 10.5m | 5.1m | 4.6m | 22.3k | 14.1m | 64.9m | 58.1m | 41.7m | 30.0m |
PP&E | 1.4m | 1.2m | 1.0m | 1.0m | 834.0k | 541.0k | 419.0k | 298.0k | 213.0k | 225.0 | 161.0k | 361.0k | 724.0k | 726.0k | 632.0k |
GBP | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.2m) | (6.3m) | (5.2m) | (6.6m) | (3.7m) | (5.8m) | (6.1m) | (6.2m) | (6.3m) | (7.1k) | (8.9m) | (11.4m) | (15.6m) | (17.6m) | (14.3m) |
Cash From Operating Activities | 3.2m | 5.0m | 6.0m | (6.1m) | (4.4m) | (2.6m) | (5.1m) | (5.8m) | (6.0m) | (6.0k) | (8.2m) | (11.9m) | (12.6m) | (14.9m) | (12.0m) |
Cash From Financing Activities | 1.0m | 9.3m | 7.9m | 1.2m | 2.5m | 7.2m | 9.3m | 91.0k | 5.6m | 17.4k | 6.0m | 16.9m | 23.3m | 14.5m | 4.4m |
Net Change in Cash | 62.0k | 5.1m | 2.5m | (4.9m) | (1.8m) | 4.6m | 4.1m | (5.7m) | (436.0k) | 11.4k | (2.5m) | 5.0m | 10.7m | (214.0k) | (7.5m) |
GBP | FY, 2005 |
---|---|
Financial Leverage | -1.3 x |
When was Reneuron Group founded?
Reneuron Group was founded in 1997.
Who are Reneuron Group key executives?
Reneuron Group's key executives are Olav Hellebo, Simon Cartmell and Richard Beckman.
How many employees does Reneuron Group have?
Reneuron Group has 53 employees.
What is Reneuron Group revenue?
Latest Reneuron Group annual revenue is £49 k.
What is Reneuron Group revenue per employee?
Latest Reneuron Group revenue per employee is £925 .
Who are Reneuron Group competitors?
Competitors of Reneuron Group include Eloxx Pharmaceuticals, Personal Genome Diagnostics (PGD) and Touchlight Genetics.
Where is Reneuron Group headquarters?
Reneuron Group headquarters is located at Pencoed Business Park, Pencoed.
Where are Reneuron Group offices?
Reneuron Group has offices in Pencoed and Surrey Research Park.
How many offices does Reneuron Group have?
Reneuron Group has 2 offices.
Receive alerts for 300+ data fields across thousands of companies